Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 11, 2025, 4:00 PM EDT
Seelos Therapeutics Market Cap
Seelos Therapeutics has a market cap or net worth of $1.00 as of August 22, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
1.00
Enterprise Value
9.86M
Revenue
2.01M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since January 24, 2019, Seelos Therapeutics's market cap has decreased from 23.95M to 1.00, a decrease of -100.00%. That is a compound annual growth rate of -92.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 1.00 | -100.00% |
| Dec 31, 2024 | 101.27K | -99.26% |
| Dec 29, 2023 | 13.61M | -81.29% |
| Dec 30, 2022 | 72.77M | -57.68% |
| Dec 31, 2021 | 171.95M | 103.72% |
| Dec 31, 2020 | 84.41M | 133.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |